This rearrangement should be investigated in FL cases lacking BCL2 expression on IHC to distinguish FL from other low-grade B-cell lymphomas, such as marginal zone lymphoma. This evidence concerns the gene BCL2 and B-cell non-Hodgkin lymphoma.